L. Laurén

542 total citations
26 papers, 451 citations indexed

About

L. Laurén is a scholar working on Oncology, Molecular Biology and Orthopedics and Sports Medicine. According to data from OpenAlex, L. Laurén has authored 26 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Orthopedics and Sports Medicine. Recurrent topics in L. Laurén's work include Bone health and treatments (17 papers), Bone Metabolism and Diseases (9 papers) and Bone health and osteoporosis research (8 papers). L. Laurén is often cited by papers focused on Bone health and treatments (17 papers), Bone Metabolism and Diseases (9 papers) and Bone health and osteoporosis research (8 papers). L. Laurén collaborates with scholars based in Finland and Sweden. L. Laurén's co-authors include T. Österman, R. Hannuniemi, K. Kippo, R. Sellman, Peter Reizenstein, H. Kalervo Väänänen, Leif Stenke, Erkka Syvälahti, Vesa Lepola and M. O. Karlsson and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Bone and Mineral Research and European Journal of Pharmacology.

In The Last Decade

L. Laurén

26 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Laurén Finland	15	250	189	180	66	41	26	451
Kevin McAndrews United States	9	161 0.6×	140 0.7×	333 1.9×	40 0.6×	38 0.9×	19	514
Colette Fong-Yee Australia	9	144 0.6×	52 0.3×	118 0.7×	40 0.6×	37 0.9×	12	344
Angela M. Inzerillo United States	9	135 0.5×	124 0.7×	224 1.2×	32 0.5×	42 1.0×	10	487
Ben‐hua Sun United States	12	205 0.8×	71 0.4×	300 1.7×	35 0.5×	92 2.2×	20	511
James M. Pash United States	15	86 0.3×	35 0.2×	401 2.2×	37 0.6×	36 0.9×	18	643
Carole Elford United Kingdom	10	88 0.4×	47 0.2×	169 0.9×	53 0.8×	78 1.9×	15	421
S Pun United States	12	174 0.7×	147 0.8×	237 1.3×	29 0.4×	10 0.2×	15	439
WELDON LLOYD United States	11	134 0.5×	33 0.2×	165 0.9×	54 0.8×	8 0.2×	18	357
Peter Paruzel Germany	4	58 0.2×	77 0.4×	204 1.1×	85 1.3×	28 0.7×	9	329
Shino Kondoh Japan	5	130 0.5×	133 0.7×	262 1.5×	17 0.3×	26 0.6×	8	406

Countries citing papers authored by L. Laurén

Since Specialization

Citations

This map shows the geographic impact of L. Laurén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Laurén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Laurén more than expected).

Fields of papers citing papers by L. Laurén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Laurén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Laurén. The network helps show where L. Laurén may publish in the future.

Co-authorship network of co-authors of L. Laurén

This figure shows the co-authorship network connecting the top 25 collaborators of L. Laurén. A scholar is included among the top collaborators of L. Laurén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Laurén. L. Laurén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kippo, K., R. Hannuniemi, L. Laurén, et al.. (1998). Effect of clodronate treatment on established bone loss in ovariectomized rats. Bone. 23(4). 333–342. 11 indexed citations

Österman, T., L. Laurén, R. Hannuniemi, et al.. (1998). The Effect of Orally Administered Clodronate on Bone Mineral Density and Bone Geometry in Ovariectomized Rats. Journal of Pharmacology and Experimental Therapeutics. 284(1). 312–316. 11 indexed citations

Österman, T., et al.. (1997). A comparison of clodronate and indomethacin in the treatment of adjuvant arthritis. Inflammation Research. 46(3). 79–85. 22 indexed citations

Kippo, K., R. Hannuniemi, L. Laurén, et al.. (1997). Clodronate Prevents Bone Loss in Aged Ovariectomized Rats. Calcified Tissue International. 61(2). 151–157. 12 indexed citations

Österman, T., et al.. (1997). Distribution of Clodronate in the Bone of Adult Rats and Its Effects on Trabecular and Cortical Bone. Journal of Pharmacology and Experimental Therapeutics. 280(2). 1051–1056. 9 indexed citations

Lepola, Vesa, R. Hannuniemi, K. Kippo, et al.. (1996). Long-term effects of clodronate on growing rat bone. Bone. 18(2). 191–196. 37 indexed citations

Kippo, K., R. Hannuniemi, L. Laurén, et al.. (1995). The effects of clodronate on increased bone turnover and bone loss due to ovariectomy in rats. Bone. 17(6). 533–542. 16 indexed citations

Österman, T., K. Kippo, L. Laurén, R. Hannuniemi, & R. Sellman. (1995). Effect of clodronate on established collagen-induced arthritis in rats. Inflammation Research. 44(6). 258–263. 32 indexed citations

Paavolainen, Pekka, et al.. (1995). Short term clodronate treatment does not increase trabecular bone in posttraumatic osteopenia.. PubMed. 84(3). 296–301. 6 indexed citations

10.

Österman, T., et al.. (1994). Effect of Iron on the Absorption and Distribution of Clodronate after Oral Administration in Rats. Pharmacology & Toxicology. 74(6). 267–270. 4 indexed citations

11.

Österman, T., K. Kippo, L. Laurén, R. Hannuniemi, & R. Sellman. (1994). Effect of clodronate on established adjuvant arthritis. Rheumatology International. 14(4). 139–147. 42 indexed citations

12.

Laurén, L., et al.. (1991). Pharmacokinetics of Clodronate after Single Intravenous, Intramuscular and Subcutaneous Injections in Rats. Pharmacology & Toxicology. 69(5). 365–368. 19 indexed citations

13.

Österman, T. & L. Laurén. (1991). Level of Clodronate in Bone after Single and Repeated Subcutaneous Injections in Rats. Pharmacology & Toxicology. 69(5). 369–371. 10 indexed citations

14.

Leino, L., et al.. (1990). The determination of histamine in challenged human leukocyte preparations by high-performance liquid chromatography. Inflammation Research. 31(3-4). 178–182. 4 indexed citations

15.

Hanhijärvi, H, Inkeri Elomaa, M. O. Karlsson, & L. Laurén. (1989). Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive days.. PubMed. 27(12). 602–6. 25 indexed citations

16.

Laurén, L., et al.. (1989). Survival, hospitalization and cause of death in 99 patients with the myelodysplastic syndrome.. PubMed. 9(4). 893–6. 15 indexed citations

17.

Syvälahti, Erkka, et al.. (1988). Effects of Antiparkinsonian Drugs on Muscarinic Receptor Binding in Rat Brain, Heart and Lung. Pharmacology & Toxicology. 62(2). 90–94. 24 indexed citations

18.

Iisalo, E, Timo Kaila, & L. Laurén. (1988). Radioreceptor assay of anticholinergic drugs.. PubMed. 20(5). 367–72. 3 indexed citations

19.

Syvälahti, Erkka, et al.. (1987). Interaction of Psychotropic Drugs with Brain Muscarinic Cholinoceptors: Similarities of Biperiden with Pirenzepine in Receptor Binding Properties. Pharmacology & Toxicology. 60(1). 66–69. 21 indexed citations

20.

Laurén, L., et al.. (1987). Serum antimuscarinic activity after a single dose of oral scopolamine hydrobromide solution measured by radioreceptor assay. Oral Surgery Oral Medicine Oral Pathology. 63(5). 534–538. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact